BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
Leading pharmaceutical research outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH), announced on Tuesday that it has agreed to transfer its entire equity stakes in Advanced Therapies and Oxford Genetics…
Recent Articles
BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
2359.HK
603259.SHG
RELATED ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK -
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
-
A Drug Company’s Forced Sales, and a Family Feud in Shanghai
2269.HK 2359.HK
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
BRIEF: Taiwan lifts advanced chip manufacturing export restrictions for U.S.
TSM.US 2330.TW
